Inducible nitric oxide synthase: An asset to neutrophils.


Journal

Journal of leukocyte biology
ISSN: 1938-3673
Titre abrégé: J Leukoc Biol
Pays: England
ID NLM: 8405628

Informations de publication

Date de publication:
01 2019
Historique:
received: 11 04 2018
revised: 25 08 2018
accepted: 26 08 2018
pubmed: 5 10 2018
medline: 17 10 2019
entrez: 5 10 2018
Statut: ppublish

Résumé

Neutrophils play a key role in innate immune responses against foreign intrusion and influence the subsequent instigation of adaptive immune response. Nitric oxide (NO) synthesized by neutrophil nitric oxide synthase (NOS) profoundly modulates their diverse physiological responsibilities furthermore encompassing pathological implications. Neutrophils are the active participants in diverse inflammatory and cardiovascular disorders but neutrophil nitric oxide synthase (NOS) remains enigmatic on various aspects. This review focuses on inducible NOS (iNOS) and makes an attempt to address its potential impact in neutrophil pathophysiology, their differentiation, functionality, and survival. We described the scenario from its expressional modulation, by pro- and anti-inflammatory cytokines governing the extent and duration of neutrophil immune response, to iNOS catalysis, the intracellular compartmentalization, and protein-protein interactions determining its microenvironment, activity and its contribution as a potential signaling protein apart from its role as signal transducer. Further, the relevance of investigating the unexplored facets of iNOS biology in neutrophils and possible prototypes of iNOS regulation is also exemplified in related cellular systems.

Identifiants

pubmed: 30285282
doi: 10.1002/JLB.4RU0418-161R
doi:

Substances chimiques

Nitric Oxide Synthase Type II EC 1.14.13.39

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

49-61

Informations de copyright

©2018 Society for Leukocyte Biology.

Auteurs

Rashmi Saini (R)

Department of Zoology, Gargi College, University of Delhi, Delhi, 11049, India.

Sarika Singh (S)

Toxicology & Experimental Medicine, CSIR-Central Drug Research Institute, Lucknow, 226031, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH